These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8356996)

  • 21. Nabumetone induced pseudoporphyria in childhood.
    Cron RQ; Finkel TH
    J Rheumatol; 2000 Jul; 27(7):1817-8. PubMed ID: 10914877
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nabumetone, a new nonsteroidal antiinflammatory agent: clinical prospects].
    Nasonov EL; Nasonova SV
    Klin Med (Mosk); 1996; 74(8):13-6. PubMed ID: 9036198
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of particle beam mass spectrometry for the measurement of impurities in a nabumetone drug substance, not easily amenable to atmospheric pressure ionisation techniques.
    Wolff JC; Hawtin PN; Monté S; Balogh M; Jones T
    Rapid Commun Mass Spectrom; 2001; 15(4):265-72. PubMed ID: 11223957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
    Cardin S; Soll AH; Taché Y
    J Pharmacol Exp Ther; 1995 Nov; 275(2):667-73. PubMed ID: 7473153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the long-term safety experience of nabumetone.
    Willkens RF
    Drugs; 1990; 40 Suppl 5():34-7. PubMed ID: 2081490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed drug eruption due to nabumetone in a patient with previous fixed drug eruptions due to naproxen.
    Pérez-Calderón R; Gonzalo-Garijo MA; Pérez-Rangel I; Sánchez-Vega S; Zambonino MA
    J Investig Allergol Clin Immunol; 2011; 21(2):153-4. PubMed ID: 21462807
    [No Abstract]   [Full Text] [Related]  

  • 30. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic activity of nabumetone versus naproxen in acute exacerbation of osteoarthritis. A short term study.
    Cazzola M; Montrone F; Azzolini V; Vaiani G; Caruso I
    Drugs; 1990; 40 Suppl 5():78-9. PubMed ID: 2081501
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy and tolerability of nabumetone in the treatment of painful symptomatology of rheumatoid arthritis and osteoarthrosis].
    Riccieri V; Spadaro A; Iagnocco A
    Clin Ter; 1991 May; 137(3):185-9. PubMed ID: 1831086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of nabumetone in 4,541 elderly patients from a drug monitoring study.
    Münzel P; Lemmel EE
    Drugs; 1990; 40 Suppl 5():62-4. PubMed ID: 2081496
    [No Abstract]   [Full Text] [Related]  

  • 34. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
    Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M
    J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.
    Confino-Cohen R; Goldberg A
    Allergy Asthma Proc; 2003; 24(4):281-4. PubMed ID: 12974196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee].
    Gijón Baños J
    Med Clin (Barc); 1997 Jun; 109(4):130-4. PubMed ID: 9289526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analgesic activity of nabumetone in postoperative pain.
    Movilia P; Restelli L; Miriano F; Vaiani G; Grossi E
    Drugs; 1990; 40 Suppl 5():71-4. PubMed ID: 2081499
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nabumetone is an alternative].
    Melander A
    Lakartidningen; 2003 Apr; 100(17):1547. PubMed ID: 12756699
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of nabumetone on patients with RA evaluated by isokinetic muscle strength.
    Gam A; Nawrocki A; Danneskiold-Samsøe B
    Drugs; 1990; 40 Suppl 5():65-6. PubMed ID: 2081497
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].
    Lemmel EM; Stroehmann I
    Fortschr Med; 1988 Apr; 106(12):253-6. PubMed ID: 3260888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.